Bangkok Dusit Medical Services Public Company Limited
BDUUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 2.15 | 2.05 | 0.68 | 4.45 |
| FCF Yield | 2.68% | 3.04% | 3.06% | 2.60% |
| EV / EBITDA | 16.05 | 16.81 | 21.99 | 22.68 |
| Quality | ||||
| ROIC | 12.42% | 11.82% | 10.73% | 7.76% |
| Gross Margin | 36.89% | 37.12% | 36.55% | 33.56% |
| Cash Conversion Ratio | 1.13 | 1.11 | 1.23 | 1.37 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.47% | 10.65% | 10.53% | -3.45% |
| Free Cash Flow Growth | -9.58% | -17.92% | 49.10% | 102.48% |
| Safety | ||||
| Net Debt / EBITDA | 0.41 | 0.41 | 0.47 | 0.45 |
| Interest Coverage | 47.33 | 34.64 | 26.88 | 15.41 |
| Efficiency | ||||
| Inventory Turnover | 26.15 | 26.21 | 26.38 | 24.67 |
| Cash Conversion Cycle | 27.93 | 28.82 | 28.25 | 31.69 |